Zeo ScientifiX ZEOX
OTC ZEOX
$1.18 -0.28 (-19.18%)
At close: Sep 30, 2026 · 4:00 PM EDT

Zeo ScientifiX (ZEOX) EBIT Margin (2012 - 2026)

Updated

Zeo ScientifiX's EBIT Margin was -19.84% in fiscal Q2 2026 (quarter ended Apr 30, 2026), up 101.49 percentage points from -121.32% a year earlier and up 40.88 percentage points from the prior quarter.

Analysis

Zeo ScientifiX (ZEOX) EBIT Margin (2012 - 2026) Analysis & Trends

On a trailing twelve-month basis, Zeo ScientifiX's EBIT Margin was -59.10% through Apr 30, 2026, up 55.47 percentage points year-over-year; for FY2025 (ended Oct 31, 2025), it came in at -103.60%, up 11.53 percentage points from FY2024.

  • EBIT Margin shows a five-year change of +303.43 percentage points (FY2020 to FY2025).
  • In earlier fiscal years, EBIT Margin was -115.13% in FY2024 (+33.36 pp), -148.49% in FY2023 (-12.25 pp), -136.23% in FY2022 (+91.44 pp) and -227.68% in FY2021 (+179.36 pp).
  • The fiscal Q2 2026 figure marks the highest quarterly EBIT Margin since fiscal Q2 2013.
  • Compared with a year earlier, EBIT Margin has increased for three straight quarters, with an average year-over-year change of +20.57 percentage points over the last eight quarters.
  • The best year-over-year quarter for EBIT Margin over five years was fiscal Q3 2021 (a gain of 581.92 percentage points); the worst was fiscal Q4 2022 (a drop of 163.20 percentage points).
  • Per Business Quant data, ZEOX's EBIT Margin in the three fiscal quarters before Q2 2026 was -60.72% (Q1 2026), -40.39% (Q4 2025) and -158.58% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 28.21%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 37.86%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -3.52%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 32.97%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 20.57%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 34.95%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -133.21%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 28.37%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 37.40%
10 Zeo ScientifiX 9.19 Mn 5.78 Mn 2.06 Mn -19.84%
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2026 -19.84%
Jan 31, 2026 -60.72%
Oct 31, 2025 -40.39%
Jul 31, 2025 -158.58%
Apr 30, 2025 -121.32%
Jan 31, 2025 -114.95%
Oct 31, 2024 -114.55%
Jul 31, 2024 -107.06%
Apr 30, 2024 -138.28%
Jan 31, 2024 -100.69%
Oct 31, 2023 -86.64%
Jul 31, 2023 -118.43%
Apr 30, 2023 -226.39%
Jan 31, 2023 -203.36%
Oct 31, 2022 -220.36%
Jul 31, 2022 -161.24%
Apr 30, 2022 -72.52%
Jan 31, 2022 -102.64%
Oct 31, 2021 -57.16%
Jul 31, 2021 -101.83%
API Access

Zeo ScientifiX EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=ZEOX&period=max&api_key=YOUR_API_KEY